CureVac

-$3.53 (-3.61%) As of 6:32 PM UTC today

Why Robinhood?

You can buy or sell CureVac and other stocks, options, and ETFs commission-free!

About CVAC

CureVac N.V. Ordinary Shares, also called CureVac, is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA).

CEO
Franz-Werner Haas
Employees
554
Headquarters
Tubingen, Baden Wuerttemberg
Founded
2000

CVAC Key Statistics

Market Cap
16.72B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.91M
High Today
$99.57
Low Today
$94.22
Open Price
$98.00
Volume
784.53K
52 Week High
$151.80
52 Week Low
$36.15

CVAC Earnings

-$65.03
-$43.35
-$21.68
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 30, Pre-Market
Replay Earnings Call

You May Also Like

XBIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure